Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420

Published:2019-03 Issue:4 Volume:103 Page:878-886
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Lieberman Frank S.,Wang Meihua,Robins H. Ian,Tsien Christina I.,Curran Walter J.,Werner-Wasik Maria,Smith Ryan P.,Schultz Christopher,Hartford Alan C.,Zhang Peixin,Mehta Minesh P.

Funder

National Cancer Institute

Pfizer

Radiation Therapy Oncology Group

Novacure

Stemline

NCI

Collaborative Ependymoma Research Network

Genentech

Novocure

Cellectar

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference24 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

2. Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up;Stupp;Ann Oncol,2008

3. MGMT gene silencing and benefit from temozolomide in glioblastoma;Hegi;N Engl J Med,2005

4. Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma;Reardon;Cancer,2005

5. Temozolomide in combination with irinotecan for treatment of recurrent malignant glioma;Gruber;Am J Clin Oncol,2004

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing drugs in glioblastoma;New Insights Into Glioblastoma;2023

2. Reporting of tobacco use and tobacco-related analyses in cancer cooperative group clinical trials: a systematic scoping review;ESMO Open;2022-12

3. Radiomics for pseudoprogression prediction in high grade gliomas: added value of MR contrast agent;Heliyon;2022-08

4. Combined carboplatin and etoposide chemotherapy for patients with recurrent glioma;Annals of Palliative Medicine;2021-12

5. Standard 6-week chemoradiation for elderly patients with newly diagnosed glioblastoma;Scientific Reports;2021-11-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3